Diseases of the Digestive System - Liver, Phase 2b/3
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis (EPICS-III)
Volunteers
Health Professionals
What is the purpose of this trial?
Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)
- Trial withZydus Therapeutics Inc.
- Ages18 years - 75 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
- Last Updated05/12/2023
- Study HIC#2000033874